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In a cultured, renal epithelial cell line, OK, parathyroid hormone (PTH) reduces Na/phosphate cotransport 
and upon removal of the hormone the activity is regained. Cycloheximide, an inhibitor of protein synthesis, 
did not interfere with the PTH action, but prevented the reduced phosphate transport from regaining its 
original activity. Drugs, such as colchicine, that disrupt the microtubular network, lessened both the action 
of PTH and prevented the recovery of activity. The results are consistent with irreversible inactivation of 
a plasma membrane protein necessary for full activity of the Na/phosphate cotransport. 
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1. INTRODUCTION 
The OK cell line, derived from an American 
opossum kidney, has been used successfully for 
studying the regulation of Naiphosphate cotrans- 
port by parathyroid hormone (PTH) [1,2]. The 
cells respond to PTH by an immediate transient in- 
crease in intracellular Ca2+ and diacylglycerol 
(DAG) [3], rapid stimulation of adenylate cyclase 
[ 1,2,4], followed by decreased Na/H exchange ac- 
tivity [5], and decreased Nalphosphate cotrans- 
port activity [1,2]. It is generally believed that 
cyclic AMP is a mediator in the regulation of 
Naiphosphate cotransport activity in OK cells 
[ 1,2], whereas the role of Ca2+ remains unclear [3]. 
This study describes that the actual mechanism 
responsible for the decreased Naiphosphate co- 
transport is the PTH-induced inactivation of a 
protein. The protein is inactivated irreversibly, 
most likely by lysosomal degradation after having 
being endocytosed from the plasma membrane. 
Correspondence address: K. Malmstriim, Institute of 
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2. MATERIALS AND METHODS 
2.1. Materials 
The OK cells were a kind gift from Dr D. War- 
neck, San Francisco, CA. All cell culture reagents 
were purchased from Amimed (Basle); cyclohex- 
imide, colchicine and lumicolchicine from Sigma 
(St. Louis, MO) and the radiolabelled phosphate 
from New England Nuclear (Boston, MA). 
2.2. Methods 
Cells were cultured as described in [2]. For ex- 
periments, cells were plated at a density of 1-2x 
lo5 cells/35 mm dish (Nunc, Denmark), and used 
after 5 days when confluency was reached. The 
culture medium was replaced by serum-free 
medium 12-15 h before experiments. PTH and all 
other additions were made in aliquots directly to 
the medium. Na/phosphate uptake was measured 
in cell monolayers after incubation in a (37°C) 
medium containing (in mM): 137 NaCI, 5.4 KCl, 
2.8 CaClz, 1.2 MgS04, 10 Hepes-Tris, pH 7.4, 0.1 
KHz~~PO~ (0.5 &i/ml). The Na-independent 
phosphate uptake in OK cells is negligable (< 1% 
of the Na/phosphate uptake) and was therefore 
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routinely not measured [2]. The uptake was 
stopped after 3 min by washing the monolayers 4 
times with ice-cold stop solution containing (in 
mM): 137 NaCl, 14 Tris-HCl, pH 7.4. The mono- 
layer was solubilized in 1 ml of 0.5% Triton X-100 
and aliquots were used for determining the ac- 
cumulated phosphate by scintillation counting. 
3. RESULTS AND DISCUSSION 
Incubation of confluent cell monolayers with 
PTH and with PTH plus cycloheximide [6] re- 
sulted in identical reduction of the Naiphosphate 
cotransport (table 1). Similar results have been 
reported by Caverzasio et al. [I]. Inhibition of 
Na/phosphate cotransport is thus not caused by de 
novo synthesis of an inhibitory protein. Further- 
more, PTH does not prevent the synthesis of a 
regulatory protein required for full transport ac- 
tivity (negative control). If a constant turnover of 
this putative protein is assumed, PTH would, by 
suppressing the resynthesis, inhibit Na/phosphate 
cotransport. However, incubation with cyclohex- 
imide for as long as 4 h did not reduce the Na/ 
phosphate cotransport significantly in control cells 
(table 1). 
thesis, e.g. cycloheximide [6], prevented the 
recovery (fig.1). Actinomycin D [7], which in- 
terferes with the transcriptional step, had no effect 
on the recovery phase even at high concentrations 
(2 pg/ml) (not shown). 3’ -Deoxyadenosine (cor- 
dycepin), which affects messenger RNA polyaden- 
ylation [8], also delayed the recovery phase (fig. 1). 
PTH induces most likely irreversible inactivation 
of a protein that is necessary for full activity of 
Naiphosphate cotransport. The immediate control 
appears to be at the level of mRNA and the 
translation step. The necessity of de novo synthesis 
in the recovery phase was further documented by 
the effect of colchicine (fig.2). Colchicine, which 
disrupts the microtubular network, an important 
component for the intracellular routing of secre- 
tory and plasma membrane proteins [9], also 
prevented the recovery of phosphate transport. 
The mechanism of the irreversible inactivation 
was investigated by considering two possibilities: 
Ca2+-dependent proteolysis at the plasma mem- 
brane, and internalization of the protein by en- 
docytosis followed by lysosomal degradation. 
Cell monolayers which had been exposed to 
PTH exhibited reduced Naiphosphate cotrans- 
port. After removing the hormone the Na/phos- 
phate cotransport started to regain its activity 
(recovery phase), and 5-7 h later the original ac- 
tivity had returned [2]. Inhibitors of protein syn- 
Table 1 
Effect of cycloheximide on Nalphosphate cotransport in 
OK cells _- I a 
02 4 6 a 
Condition Phosphate uptake 
(nmol phosphate. mg protein-’ .3 
min-’ 
Time (h) 
Control PTH 
No addition 15.9 f 1.5 7.2 + 1.1 
Cycloheximide 15.9 f 0.6 8.2 f 0.2 
Incubation time with cycloheximide and PTH was 4 h; 
concentration of cycloheximide was 20pM and of l-34b 
PTH, lo-*’ M. Data are means + SD from a 
representative experiment performed in triplicate. 
Similar results were obtained in at least 3 other 
experiments at least 3 other experiments. 
Fig.1. Effect of protein synthesis inhibitors on the 
recovery of Na/phosphate cotransport after PTH 
removal. After 4 h incubation with lo-” M l-34b PTH, 
the culture medium containing hormone was removed 
and replaced with medium (G-XI), medium containing 
20 pM cycloheximide (A--A), or medium containing 
2OOpM cordycepin (ti); control, no PTH (o--o). 
The phosphate uptake was measured as described in 
section 2. Data are from a representative xperiment 
performed in triplicate. Similar results were observed in 
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Fig.2. Effect of colchicine and cytochalasin B on the 
recovery of Na/phosphate cotransport after PTH 
removal. For experimental details see section 2 and the 
legend to fig.1. Cell monolayers were left to recover in 
mdium (m), medium containing 10 pM colchicine 
(ti); control, no PTH (o---o). Data are means f 
SD of two independent experiments performed in 
triplicate. 
Ca2+-dependent proteases may be activated in 
response to a transient increase in cytosolic Ca2+ 
[lo]. To prevent the action of calpains we used an- 
tipain and leupeptin [1 l] at millimolar concentra- 
tion, but the action of PTH was not reduced (not 
shown). Furthermore, by selectively increasing the 
intracellular Ca2+ transiently by Ca2+ ionophores 
(ionomycin or A23187), only a minor reduction of 
Na/phosphate cotransport (< 10% after 4 h) is 
produced (not shown). Selective inactivation of a 
regulatory protein by Ca2+-dependent proteolysis 
was considered unlikely. 
Endocytosis followed by lysosomal degradation 
requires an intact microtubular network. Cell 
monolayers were exposed to colchicine and to the 
inactive analogue P-lumicolchicine [9]. In col- 
chicine-treated cells the PTH effect on Na/phos- 
phate was reduced by a factor of 2, whereas 
fl-lumicolchicine had no effect (table 2). Similar 
results were obtained with other microtubule- 
disruptive drugs such as vinblastine (not shown). It 
is proposed that the reduction of Na/phosphate 
cotransport occurs via internalization of a protein 
by endocytosis. 
In conclusion, we provide evidence that the 
recovery from the PTH-dependent inhibition of 
Table 2 
Effect of colchicine and &lumicolchicine on the 
Na/phosphate cotransport in OK cells 
Condition Phosphate uptake 
(nmol phosphate. mg protein-’ 
. min-‘) 
Control PTH % uptake 
No addition 11.0 f 1.6 3.0 + 0.3 27 
Colchicine 8.7 f 1.0 4.9 f 0.8 57 
Lumicolchicine 10.6 f 0.7 2.9 + 0.3 27 
Prior to determining the uptake, cell monolayers were 
incubated with the drugs for 4 h (control) or 1 h 
preincubation with the drugs and 3 h together with PTH. 
Concentrations of drugs were 10 pM and of PTH 
lo-” M l-34b PTH. Data are means ~fr SD from three 
independent experiments performed in triplicate. % 
uptake indicates uptake after PTH incubation as 
compared to that in control cells 
phosphate transport requires protein synthesis at 
the translational level, and an intact cytoskeletal 
system. The inhibition is most likely due to the ir- 
reversible inactivation of a protein, necessary for 
full transport activity. The experimental evidence 
supports the internalization of a membrane pro- 
tein. Hormone-induced down-regulation of trans- 
port systems has not been described so far, 
although up-regulation, e.g. vasopressin-stimu- 
lated water transport [ 121 and insulin-stimulated 
glucose transport [13], is known. More knowledge 
is required about the molecular structure of the 
Na/ phosphate carrier before it will be possible to 
distinguish whether the endocytosed protein is the 
Na/phosphate carrier or an activator protein. 
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